Your browser doesn't support javascript.
loading
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
Takashita, Emi; Kinoshita, Noriko; Yamayoshi, Seiya; Sakai-Tagawa, Yuko; Fujisaki, Seiichiro; Ito, Mutsumi; Iwatsuki-Horimoto, Kiyoko; Chiba, Shiho; Halfmann, Peter; Nagai, Hiroyuki; Saito, Makoto; Adachi, Eisuke; Sullivan, David; Pekosz, Andrew; Watanabe, Shinji; Maeda, Kenji; Imai, Masaki; Yotsuyanagi, Hiroshi; Mitsuya, Hiroaki; Ohmagari, Norio; Takeda, Makoto; Hasegawa, Hideki; Kawaoka, Yoshihiro.
Afiliación
  • Takashita E; National Institute of Infectious Diseases, Tokyo, Japan.
  • Kinoshita N; National Center for Global Health and Medicine, Tokyo, Japan.
  • Yamayoshi S; University of Tokyo, Tokyo, Japan.
  • Sakai-Tagawa Y; University of Tokyo, Tokyo, Japan.
  • Fujisaki S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Ito M; University of Tokyo, Tokyo, Japan.
  • Iwatsuki-Horimoto K; University of Tokyo, Tokyo, Japan.
  • Chiba S; University of Wisconsin-Madison, Madison, WI.
  • Halfmann P; University of Wisconsin-Madison, Madison, WI.
  • Nagai H; University of Tokyo, Tokyo, Japan.
  • Saito M; University of Tokyo, Tokyo, Japan.
  • Adachi E; University of Tokyo, Tokyo, Japan.
  • Sullivan D; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Pekosz A; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Watanabe S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Maeda K; National Center for Global Health and Medicine, Tokyo, Japan.
  • Imai M; University of Tokyo, Tokyo, Japan.
  • Yotsuyanagi H; University of Tokyo, Tokyo, Japan.
  • Mitsuya H; National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; National Center for Global Health and Medicine, Tokyo, Japan.
  • Takeda M; National Institute of Infectious Diseases, Tokyo, Japan.
  • Hasegawa H; National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawaoka Y; University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.
N Engl J Med ; 386(10): 995-998, 2022 03 10.
Article en En | MEDLINE | ID: mdl-35081300
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / SARS-CoV-2 / Anticuerpos Monoclonales Idioma: En Revista: N Engl J Med Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / SARS-CoV-2 / Anticuerpos Monoclonales Idioma: En Revista: N Engl J Med Año: 2022 Tipo del documento: Article País de afiliación: Japón